Severe rash associated with vemurafenib administration following nivolumab therapy
Author:
Affiliation:
1. Tokyo Metropolitan Cancer and Infectious Diseases Center; Komagome Hospital; Tokyo Japan
2. Department of Dermatology; Hokkaido University Graduate School of Medicine; Sapporo Japan
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13331/fullpdf
Reference5 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011
4. Vemurafenib sensitivity skin reaction after ipilimumab;Harding;N Engl J Med,2012
5. Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy;Johnson;Cancer Immunol Res,2013
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunological Drug–Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies;Chemical Research in Toxicology;2024-06-24
2. Hand‐foot syndrome histopathologically presenting eccrine squamous syringometaplasia due to pembrolizumab after lenvatinib treatment;Journal of Cutaneous Pathology;2023-07-12
3. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review;Supportive Care in Cancer;2021-09-21
4. Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies;Cancer Management and Research;2018-05
5. Granulomatous and lichenoid dermatitis after IgG4 anti-PD-1 monoclonal antibody therapy for advanced cancer;Journal of Cutaneous Pathology;2018-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3